NasdaqGM:TCMD

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Tactile Systems Technology

Executive Summary

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices for chronic diseases in the United States. More Details


Snowflake Analysis

Flawless balance sheet with high growth potential.

Share Price & News

How has Tactile Systems Technology's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: TCMD is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: TCMD's weekly volatility (8%) has been stable over the past year.


Market Performance


7 Day Return

-0.7%

TCMD

2.2%

US Medical Equipment

1.5%

US Market


1 Year Return

-33.9%

TCMD

20.0%

US Medical Equipment

22.3%

US Market

Return vs Industry: TCMD underperformed the US Medical Equipment industry which returned 19% over the past year.

Return vs Market: TCMD underperformed the US Market which returned 22.1% over the past year.


Shareholder returns

TCMDIndustryMarket
7 Day-0.7%2.2%1.5%
30 Day16.6%3.4%8.8%
90 Day18.3%8.8%10.8%
1 Year-33.9%-33.9%21.0%20.0%25.1%22.3%
3 Year53.7%53.7%76.0%71.5%49.5%39.6%
5 Yearn/a147.7%128.7%105.8%83.3%

Long-Term Price Volatility Vs. Market

How volatile is Tactile Systems Technology's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Tactile Systems Technology undervalued compared to its fair value and its price relative to the market?

7.53x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate TCMD's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate TCMD's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: TCMD is unprofitable, so we can't compare its PE Ratio to the US Medical Equipment industry average.

PE vs Market: TCMD is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate TCMD's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: TCMD is overvalued based on its PB Ratio (7.5x) compared to the US Medical Equipment industry average (4.4x).


Next Steps

Future Growth

How is Tactile Systems Technology forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?

85.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: TCMD is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.2%).

Earnings vs Market: TCMD is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: TCMD's is expected to become profitable in the next 3 years.

Revenue vs Market: TCMD's revenue (20% per year) is forecast to grow faster than the US market (10.2% per year).

High Growth Revenue: TCMD's revenue (20% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if TCMD's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Tactile Systems Technology performed over the past 5 years?

10.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: TCMD is currently unprofitable.

Growing Profit Margin: TCMD is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: TCMD is unprofitable, but has reduced losses over the past 5 years at a rate of 10.4% per year.

Accelerating Growth: Unable to compare TCMD's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: TCMD is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (0.2%).


Return on Equity

High ROE: TCMD has a negative Return on Equity (-7.74%), as it is currently unprofitable.


Next Steps

Financial Health

How is Tactile Systems Technology's financial position?


Financial Position Analysis

Short Term Liabilities: TCMD's short term assets ($114.1M) exceed its short term liabilities ($25.6M).

Long Term Liabilities: TCMD's short term assets ($114.1M) exceed its long term liabilities ($23.0M).


Debt to Equity History and Analysis

Debt Level: TCMD is debt free.

Reducing Debt: TCMD has no debt compared to 5 years ago when its debt to equity ratio was 0.02%.

Debt Coverage: TCMD has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: TCMD has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Next Steps

Dividend

What is Tactile Systems Technology current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate TCMD's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate TCMD's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if TCMD's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if TCMD's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of TCMD's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.3yrs

Average management tenure


CEO

Dan Reuvers (57 yo)

0.50

Tenure

Mr. Daniel L. Reuvers, also known as Dan, has been President, Chief Executive Officer and Director of Tactile Systems Technology, Inc. since June 8, 2020. He served as Executive Vice President and Presiden...


Leadership Team

NamePositionTenureCompensationOwnership
Brent Moen
Chief Financial Officer2.25yrsUS$905.57k0.018%
$ 144.4k
Bryan Rishe
Senior Vice President of Sales12.92yrsUS$957.57k0.092%
$ 755.3k
Gerald Mattys
Consultant0.50yrUS$2.81m1.51%
$ 12.4m
Daniel Reuvers
President0.50yrno datano data
Peter Schaubach
Chief Information Officer1.92yrsno datano data
Sunday Hoy
VP & Compliance Officerno datano datano data
Darren Wennen
Vice President of Marketing & Clinical Affairs6.92yrsno datano data
Juleen Krings
Chief Human Resources Officer2.33yrsno datano data
Thomas O'Donnell
Chief Medical Officer3.42yrsno datano data

2.3yrs

Average Tenure

58.5yo

Average Age

Experienced Management: TCMD's management team is considered experienced (2.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Daniel Reuvers
President0.50yrno datano data
Richard Nigon
Independent Director8.25yrsUS$189.98k0.54%
$ 4.4m
Raymond Huggenberger
Independent Director3.25yrsUS$177.48k0.013%
$ 110.7k
William Burke
Independent Director5.25yrsUS$189.98k0.016%
$ 134.2k
Peter Soderberg
Independent Chairman7.92yrsUS$219.98k0.57%
$ 4.7m
Cheryl Pegus
Independent Director3.42yrsUS$177.48k0.018%
$ 150.5k
Kevin Roche
Independent Director16.17yrsUS$184.98k0.17%
$ 1.4m
Steven Dean
Member of Vascular Scientific Advisory Boardno datano datano data
Christopher Pittman
Member of Vascular Scientific Advisory Boardno datano datano data
Antonios Gasparis
Chairman of Vascular Scientific Advisory Boardno datano datano data
Ron Karni
Member of Head & Neck Scientific Advisory Boardno datano datano data
Kush Desai
Member of Vascular Scientific Advisory Boardno datano datano data

5.3yrs

Average Tenure

61yo

Average Age

Experienced Board: TCMD's board of directors are considered experienced (5.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.1%.


Top Shareholders

Company Information

Tactile Systems Technology, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Tactile Systems Technology, Inc.
  • Ticker: TCMD
  • Exchange: NasdaqGM
  • Founded: 1995
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$822.052m
  • Shares outstanding: 19.42m
  • Website: https://www.tactilemedical.com

Number of Employees


Location

  • Tactile Systems Technology, Inc.
  • 3701 Wayzata Boulevard
  • Suite 300
  • Minneapolis
  • Minnesota
  • 55416
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
TCMDNasdaqGM (Nasdaq Global Market)YesCommon StockUSUSDJul 2016
3L3DB (Deutsche Boerse AG)YesCommon StockDEEURJul 2016

Biography

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compr...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/12/05 00:24
End of Day Share Price2020/12/04 00:00
Earnings2020/09/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.